Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV
about
Pathogenesis of human immunodeficiency virus infectionImmunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIV.Occult systemic infection and persistent simian immunodeficiency virus (SIV)-specific CD4(+)-T-cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIVEvidence for viral virulence as a predominant factor limiting human immunodeficiency virus vaccine efficacy.Postinoculation PMPA treatment, but not preinoculation immunomodulatory therapy, protects against development of acute disease induced by the unique simian immunodeficiency virus SIVsmmPBj.In vivo attenuation of simian immunodeficiency virus by disruption of a tyrosine-dependent sorting signal in the envelope glycoprotein cytoplasmic tail.Effect of CD8+ lymphocyte depletion on virus containment after simian immunodeficiency virus SIVmac251 challenge of live attenuated SIVmac239delta3-vaccinated rhesus macaques.The nef gene of simian immunodeficiency virus SIVmac1A11A combination DNA and attenuated simian immunodeficiency virus vaccine strategy provides enhanced protection from simian/human immunodeficiency virus-induced disease.Current progress in the development of a prophylactic vaccine for HIV-1.Non-human primate models for AIDS vaccine research.Role of CD8+ cells in controlling replication of nonpathogenic Simian Immunodeficiency Virus SIVmac1A11.Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA VirusesEarly events in tissues during infection with pathogenic (SIVmac239) and nonpathogenic (SIVmac1A11) molecular clones of simian immunodeficiency virus.Viral factors determine progression to AIDS in simian immunodeficiency virus-infected newborn rhesus macaques.Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine.Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara.Simian immunodeficiency virus DNA vaccine trial in macaques.Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of human immunodeficiency virus type 1.Early cytokine and chemokine gene expression in lymph nodes of macaques infected with simian immunodeficiency virus is predictive of disease outcome and vaccine efficacy.Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus.Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus.Role of the long cytoplasmic domain of the SIV Env glycoprotein in early and late stages of infection.Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters the conformation of the external domain.A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge.Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection.Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmacAlterations in potential sites for glycosylation predominate during evolution of the simian immunodeficiency virus envelope gene in macaques.Identification of viral determinants of macrophage tropism for simian immunodeficiency virus SIVmac.Method for detection of simian immunodeficiency virus neutralizing antibodies using a noncommercial antigen capture enzyme-linked immunosorbent assay.Development of simian immunodeficiency virus isolation, titration, and neutralization assays which use whole blood from rhesus monkeys and an antigen capture enzyme-linked immunosorbent assayHuman immunodeficiency virus type 1 infection despite prior immunization with a recombinant envelope vaccine regimen.Evolution of a simian immunodeficiency virus pathogen.Nonhuman primate models for the evaluation of HIV-1 preventive vaccine strategies: model parameter considerations and consequences.Lentivirus vectors using human and simian immunodeficiency virus elements.Diverse host responses and outcomes following simian immunodeficiency virus SIVmac239 infection in sooty mangabeys and rhesus macaques.Identification of highly attenuated mutants of simian immunodeficiency virus.Replication and persistence of simian immunodeficiency virus variants after passage in macaque lymphocytes and established human cell lines.
P2860
Q24634681-D35C86A1-8728-4ED7-B06C-D39EADD9ADA8Q33653655-DB72ECA3-32C4-493B-87DB-9D33AB1F4C47Q33786143-2A7EADC6-8040-466C-A069-239A1627D55FQ33803217-DDBB4E4D-1AF1-41B4-90D4-3D614222A291Q33820791-9E2E1842-D344-46B3-8386-BF5F34A22FA8Q33834814-9142C743-8016-4E7A-85F3-9A737293C45EQ33843308-994F03EE-18F9-4A92-B9EC-D7174AD9C6AEQ33935811-528B7AD0-1E80-48F9-87D3-6867029218D2Q34228507-011E4CF0-5E9D-4601-8AF7-8F4898FBE320Q34502108-3E88526E-3235-40D1-8E36-B90F3BD0A826Q34715769-CE2AEADC-32CE-47F5-8CCF-97D1E652FE36Q34767799-A174C021-60A3-4691-BC7B-899C5D13E63BQ34806497-B3482DF1-7625-44E1-A4F2-77B9A9190E3AQ35833990-47808708-D1D6-4E23-A398-7C072931F69FQ35841255-71691ACC-685A-4E80-A809-8B71BA1A3324Q35857571-BC341BAF-5962-4AE6-ACC2-0D61BBD1A0ACQ35861490-9F05C8FE-FE5C-49ED-9104-6E49613F14FFQ35861970-09F289D5-8F73-437E-A789-4EFE8911E54CQ35863652-F1F92AD5-2B46-4D10-958A-A1CA4D65F6F8Q35876809-97E9902D-6E3A-4158-BC5C-1C3CFF587BF3Q35895851-C79894D9-3513-45F4-958D-3CE3DFB77208Q35897786-CA610AE2-6A5B-434D-A39E-E0B2E5E7FFB6Q36459268-0F90C83D-A863-4FA4-93E6-89C5CE017C7BQ36626279-B1E4E47B-6BE9-4C49-8B2B-0CAC483139C9Q36636854-BF06A4D8-CD6E-4810-B586-4A2CD20649E8Q36640342-44E44F1A-F9FA-4185-89D9-E59DE073D21FQ36653572-A0E34C9A-6C50-4B91-8223-0F24E68E0281Q36702206-7A5D4CA0-6DD0-46AE-8392-8779133DB4FCQ36820705-786D3BFD-E0F6-4D6D-9B21-314ED309EBEEQ37121446-C560E6C5-855B-498E-978B-F222ABFF5E22Q37243637-46690EAD-C406-41A1-B389-D1B34D69BCEDQ37625485-DE817596-B5E1-4B99-ACBB-D017078961E5Q38341030-3802EA0A-9FC4-41E4-92CD-FF68A5AF0EA1Q38936872-1715F64D-E41B-4463-8605-4F8E4AECCEC8Q39549811-27845E17-507C-4FA5-90E7-A6A5BC808A69Q39582896-34D35386-2905-4E39-AF70-92F6AD8B4875Q39642374-DF1F35D4-3615-4CA4-A69E-1515A7D8B291Q40044609-3192E722-154D-4127-9B45-CD9CAC220890
P2860
Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV
description
1990 nî lūn-bûn
@nan
1990 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Immunization with a live, atte ...... challenged with pathogenic SIV
@ast
Immunization with a live, atte ...... challenged with pathogenic SIV
@en
type
label
Immunization with a live, atte ...... challenged with pathogenic SIV
@ast
Immunization with a live, atte ...... challenged with pathogenic SIV
@en
prefLabel
Immunization with a live, atte ...... challenged with pathogenic SIV
@ast
Immunization with a live, atte ...... challenged with pathogenic SIV
@en
P2093
P2860
P921
P1433
P1476
Immunization with a live, atte ...... challenged with pathogenic SIV
@en
P2093
M L Marthas
N C Pedersen
S Sutjipto
P2860
P304
P577
1990-08-01T00:00:00Z